Bynoe

A Cornell microbiologist, Margaret Bynoe, who has come up with a method to regulate the blood/brain barrier, providing the possibility of treatments for a host of brain diseases including multiple sclerosis, Parkinson's and Alzheimer's, says her first response to forming a company to move her research out of the lab was "a flat no" because she just wanted to continue working in her lab on her research seven days a week.

Angela Haines: Tech Transfers: Turn-Offs or Start-Ups? Angela Haines 2010

A Cornell microbiologist, Margaret Bynoe, who has come up with a method to regulate the blood/brain barrier, providing the possibility of treatments for a host of brain diseases including multiple sclerosis, Parkinson's and Alzheimer's, says her first response to forming a company to move her research out of the lab was "a flat no" because she just wanted to continue working in her lab on her research seven days a week.

Angela Haines: Tech Transfers: Turn-Offs or Start-Ups? Angela Haines 2010

A Cornell microbiologist, Margaret Bynoe, who has come up with a method to regulate the blood/brain barrier, providing the possibility of treatments for a host of brain diseases including multiple sclerosis, Parkinson's and Alzheimer's, says her first response to forming a company to move her research out of the lab was "a flat no" because she just wanted to continue working in her lab on her research seven days a week.

Angela Haines: Tech Transfers: Turn-Offs or Start-Ups? Angela Haines 2010

But her tech transfer office matched her with a Cornell MBA graduate who has agreed to become CEO of her newly hatched company, Adenios, for which Professor Bynoe serves as Chief Medical Officer with a significant equity stake.

Angela Haines: Tech Transfers: Turn-Offs or Start-Ups? Angela Haines 2010

But her tech transfer office matched her with a Cornell MBA graduate who has agreed to become CEO of her newly hatched company, Adenios, for which Professor Bynoe serves as Chief Medical Officer with a significant equity stake.

Angela Haines: Tech Transfers: Turn-Offs or Start-Ups? Angela Haines 2010

But her tech transfer office matched her with a Cornell MBA graduate who has agreed to become CEO of her newly hatched company, Adenios, for which Professor Bynoe serves as Chief Medical Officer with a significant equity stake.

Angela Haines: Tech Transfers: Turn-Offs or Start-Ups? Angela Haines 2010

But her tech transfer office matched her with a Cornell MBA graduate who has agreed to become CEO of her newly hatched company, Adenios, for which Professor Bynoe serves as Chief Medical Officer with a significant equity stake.

Angela Haines: Tech Transfers: Turn-Offs or Start-Ups? Angela Haines 2010

I agree with much but not all of what Bynoe writes.

UK US special relationship Marian 2009

I agree with much but not all of what Bynoe writes.

Race in europe Marian 2009

I agree with much but not all of what Bynoe writes.

Gender Marian 2008